🔎 Trials Near Me

መነሻ › የልብ ድካም › ሚዙሪ › Kansas City

በKansas City፣ MO ለየልብ ድካም የሚደረጉ ክሊኒካዊ ጥናቶች

ለየልብ ድካም የሚደረጉ 25 ጥናቶች በKansas City እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

ELEVATE-HFpEF Clinical Study

ተሳታዮችን በመፈለግ ላይ
  • Saint Lukes Mid America Heart Institute, Kansas City
እድሜ 40 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06678841

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Kansas City
  • Research Site, Kansas City
እድሜ ከ18 እስከ 130 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06307652

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Kansas City VA Medical Center, Kansas City
  • North Kansas City Hospital, North Kansas City · 2 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06424288

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Kansas City VA Medical Center, Kansas City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06935370

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Kansas City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07761117

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Saint Luke's Hospital of Kansas City, Kansas City
እድሜ ከ18 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06736574

Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure

ተሳታዮችን በመፈለግ ላይ
  • Saint Luke's Hospital of Kansas City, Kansas City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07232030

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Saint Luke's Hospital of Kansas City, Kansas City
እድሜ ከ18 እስከ 99 · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT07037459

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Kansas City
  • Research Site, Kansas City
እድሜ 40 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT06677060

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Kansas City, MO Investigative Site 10002, Kansas City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT06008197

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • CON-10002 Kansas City, MO Investigative Site, Kansas City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT06024746

The WiSE®-UP Study (The WiSE System Utilization & Performance Study)

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • St. Luke's Hospital of Kansas City, Kansas City
እድሜ 22 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT07098858

A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Local Institution - 145, Kansas City
እድሜ ከ30 እስከ 84 · ሁሉም ጾታዎች · የተሻሻለው በ31 ኦገስ 2026 · NCT07795814

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Kansas City, Kansas City
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT00271180

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • St. Luke's Mid-America Heart Institute, Kansas City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT05489705

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Tenax Investigational Site, Kansas City
እድሜ ከ18 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT07288398

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Clinical Research Consultants, JCCT Co, Kansas City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ኦገስ 2026 · NCT07567001

Assessment of CCM in HF With Higher Ejection Fraction

ተሳታዮችን በመፈለግ ላይ
  • St. Lukes Hospital Kansas City (Mid America Heart Institute), Kansas City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT05064709

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • FIN-10002 Kansas City, MO Investigational Site, Kansas City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁላይ 2026 · NCT06033950

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

ተሳታዮችን በመፈለግ ላይ
  • St. Lukes/ Mid-American Heart Institute, Kansas City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁን 2026 · NCT05934487

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Children's Mercy Hospital Kansas City - Cardiology, Kansas City
እስከ እድሜ 18 · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁን 2026 · NCT07192952

A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Children's Mercy Hospital Kansas City - Cardiology, Kansas City
6 Months – 17 Years · ሁሉም ጾታዎች · የተሻሻለው በ15 ጁን 2026 · NCT07188805

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

ተሳታዮችን በመፈለግ ላይ
  • St. Luke's Hospital, Kansas City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁን 2026 · NCT06526195

CCM OPEN HF Registry

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Saint Luke's Hospital Mid America Heart Institute, Kansas City
  • Saint Luke's Hospital of Kansas City, Kansas City
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ኤፕሪ 2026 · NCT07112924

HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Saint Luke's Health System, Kansas City
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሜይ 2024 · NCT06425848

በሌሎች ከተሞች ለየልብ ድካም የሚደረጉ ጥናቶች

በKansas City ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።